VEGFA and stroke disorder: In animal model of stroke, the IV ASCs administration was founded to be safe and to improve the stroke outcome by promoting blood vessel formation and axonal sprouting by increasing the VEGF levels and decreasing apoptosis and glial scar formation [28, 29].